盐酸法舒地尔对急性脑梗死患者血清超敏C反应蛋白和血管内皮生长因子的影响

来源 :中国实用医药 | 被引量 : 0次 | 上传用户:xxq0108
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察盐酸法舒地尔对急性脑梗死患者血清超敏C反应蛋白和血管内皮生长因子的影响。方法 86例急性脑梗死患者随机分为两组,治疗组46例,对照组40例。对照组采用常规治疗,治疗组在常规治疗基础上加用法舒地尔,共观察21 d。治疗前后测定血清超敏C反应蛋白(hs-CRP)和血管内皮生长因子(VEGF)。结果两组在治疗7、21 d后神经功能均有明显好转,并且治疗组改善程度在7、21 d均优于对照组(P<0.05)。两组在治疗后hs-CRP和VEGF均有显著降低,并且治疗组降低程度更明显(P<0.05)。结论法舒地尔可以减少急性脑梗死患者hs-CRP和VEGF的表达,从而改善病情。 Objective To observe the effect of fasudil hydrochloride on serum high sensitive C-reactive protein and vascular endothelial growth factor in patients with acute cerebral infarction. Methods A total of 86 patients with acute cerebral infarction were randomly divided into two groups: treatment group (46 cases) and control group (40 cases). The control group was treated routinely, and the treatment group was given fasudil on the basis of routine treatment for a total of 21 days. Serum high sensitivity C-reactive protein (hs-CRP) and vascular endothelial growth factor (VEGF) were measured before and after treatment. Results The neurological function of both groups improved obviously after 7 and 21 days of treatment, and the improvement of the treatment group was better than that of the control group on 7 and 21 days (P <0.05). The hs-CRP and VEGF in both groups were significantly decreased after treatment, and the treatment group decreased more significantly (P <0.05). Conclusion fasudil can reduce the expression of hs-CRP and VEGF in patients with acute cerebral infarction, thereby improving the condition.
其他文献
期刊
目的 观察伤柏膏贴剂外敷治疗急性软组织损伤的临床研究.方法 根据纳入标准选择的急性软组织损伤患者200例,随机分成治疗组和对照组.治疗组给予伤柏膏贴剂(巴布剂)外敷患处,
建立了液相色谱-串联质谱法同时测定大鼠血浆中蒿甲醚及其活性代谢物双氢青蒿素的浓度.以未修饰的蒿甲醚纳米结构脂质载体(NLC)作对照,考察聚乙二醇(PEG)修饰体系(PEG-NLC)经
期刊
期刊
期刊
期刊
通过阐述国内外移动医疗服务的形成与发展,介绍了移动医疗的主要应用领域,同时也分析了当前我国移动医疗服务中存在的不足,如健康数据可靠性问题、网络诊疗安全性问题、网络
期刊
期刊